← livingvaluetheory.orgInvisible illness is not the name for a class of medically mysterious conditions. It is the name for a structural position in modern recognition regimes: suffering that is real in lived coordination but cannot secure stable passage through the symbolic classifications that gate care, income, legitimacy, and social support.
Two recent contributions to medical anthropology map this position with unusual care. Emily Mendenhall's Invisible Illness: A History from Hysteria to Long COVID traces the long arc of conditions that fail to achieve institutional recognition within biomedical systems, from nineteenth-century hysteria through chronic fatigue syndrome, chronic Lyme disease, fibromyalgia, and long COVID. Bridget Bradley's publications on body-focused repetitive behaviours (e.g., Bradley 2021) shows how people with compulsive hair pulling and skin picking move from radical isolation into community, and how that community generates advocacy that brings further people in. Both their writings are concerned with what happens when suffering cannot pass through the institutional gates th-at govern access to care, income, legitimacy, and social support.
The concept both invoke is recognition. It is the right concept, but it requires further theoretical elaboration that neither text provides. Recognition, this essay argues, is not a single event in which medicine sees or fails to see suffering. It is a distributed institutional achievement. It depends on the partial alignment of clinicians, diagnostic systems, employers, insurers, welfare agencies, families, patient communities, and digital platforms. Invisible illness names the structural position occupied by suffering that is real in lived coordination but cannot secure stable passage across this recognition chain.
That recognition chain is not a natural feature of human social life. It is a historically produced institutional configuration, assembled across the last century and a half through the convergence of several distinct conditions, none of which alone was sufficient. The recognition crisis that both texts document is not a failure of a system that has always existed. It is a structural consequence of a system that is historically recent, internally contradictory, and still being assembled.
This essay develops that argument in five movements. The first specifies what invisible illness is as a structural position. The second examines what recognition actually is as an institutional operation. The third maps the recognition architectures that both texts document, attending carefully to who recognises, through what mechanisms, and to what effects, including the foundational claim that patient advocacy creates access to others, not merely access to biomedical classification. The fourth makes the historical argument, tracing the convergence of conditions that produced recognition-dependent suffering as a modern phenomenon. The fifth draws the argument together and asks what the recognition crisis reveals about the configuration that generates it.
I. Invisible Illness as Structural Position
The concept of invisible illness has been used, in both popular and scholarly discourse, to name conditions that are hard to see: chronic fatigue, neurological dysfunction, diffuse pain, cognitive disruption. The implication is that the problem is one of visibility, of medicine failing to look carefully enough at what is there.
This framing is inexact in a way that matters. The suffering documented in both Mendenhall's and Bradley's texts is not invisible in any ordinary sense. Bethany's hair loss, weight loss, blue extremities, and inability to climb the stairs between floors of her own house were entirely visible to anyone present. The people with trichotillomania whom Bradley studied pulled out their hair, producing bald patches that others noticed and responded to, often with alarm or derision. The problem is not that the suffering cannot be seen. It is that what can be seen does not activate the responses that matter.
Legibility is a closer candidate. The argument would be that suffering needs to be made readable within authorised frameworks, communicated in terms that institutions can process. But the patients in both books are often highly legible. The ME/CFS patients who contested the PACE Trial were extraordinarily articulate, informed, and strategically sophisticated. The long COVID patients Mendenhall documents arrive at clinical appointments with research printed and symptom diaries carefully maintained. Bradley's BFRB community members become expert self-advocates. The problem is not that they cannot make themselves understood. It is that understanding, even when achieved, does not reliably produce the responses they need.
The right concept is recognition, and what is needed is a precise account of what recognition is, where it operates, and why it fails in the ways both texts document. That account begins from the observation that recognition is not a simple seeing but a distributed institutional achievement, and that its failure is correspondingly distributed across multiple sites, not concentrated in the clinical encounter.
Invisible illness, then, names a structural position: the position of suffering that is real in the actual texture of lived experience, in the body's failures, in the dissolution of social connection, in the deterioration of home and material support, but that cannot achieve stable passage through the symbolic classifications that gate institutional response. The person in this position is not unseen. They are unrecognised in the specific, consequential sense that the institutions whose response would make a difference cannot or do not process what they are experiencing as falling within the categories that would activate response.
This structural position is not confined to the medical conditions that both texts document. It extends to any domain in which suffering that is real in lived experience is systematically excluded from the symbolic categories through which institutional recognition operates. Workplace harm that cannot be formally acknowledged without triggering institutional liability, neurodivergence in educational and occupational settings built around classification systems not designed for this range of human variation, grief and exhaustion that fall below the threshold of any authorised intervention: all of these share the same structural position. The invisible illness literature is the most developed account of this position, but it is not its only instance.
II. Recognition as Institutional Operation
Recognition is so thoroughly embedded in ordinary language that it appears transparent, a simple seeing of what is there. To recognise something is, apparently, to acknowledge it, to register its presence correctly. This apparent transparency conceals a complex and consequential institutional operation.
In Living Value Theory, symbolic operations can be assessed for their structural properties: what domains of lived coordination do they claim to address, and how well does their symbolic form track the coordination they claim to describe? Recognition, examined this way, turns out to be neither simple nor neutral.
Recognition, in the modern institutional sense, is the operation through which an authorised actor makes a classification consequential. A patient's description of their suffering is one thing. A clinician's diagnosis of that suffering is another. The difference is not primarily epistemic. It is positional and institutional. The clinician's diagnostic act is taken up by insurance systems, welfare agencies, employers, and legal structures as a basis for decision, entitlement, exclusion, and coordinated response. The patient's self-description, however accurate, however articulate, does not activate those responses without passing through the gate of authorised classification.
This is why recognition matters so disproportionately, and why fighting over diagnostic labels is not the petty semantic quarrel it sometimes appears from outside patient communities. The label is not a description. It is a switch. Its presence or absence determines whether care is reimbursable, whether sick leave is legitimated, whether disability payments flow, whether legal protections apply, whether the person's account of their experience is treated as credible in clinical, domestic, and social settings. Recognition is consequential classification, and its consequences are what make its failure so catastrophic.
This also means that recognition carries all the structural risks of any consequential classification system. A diagnostic category can be internally coherent, clinically useful in limited domains, and institutionally well-embedded while remaining profoundly misaligned with the actual structure of the suffering it claims to describe. Major Depressive Disorder attends primarily to embodiment and inner experience while largely suppressing the dimensions of social disconnection, housing instability, and material deprivation that sustain the same suffering in many of the cases Mendenhall documents. Functional Neurological Disorder attends to the absence of structural damage while actively redirecting clinical attention away from the pathogen hypothesis that many patients believe explains their condition. These are not merely diagnostic errors. They are institutional closures: the classification forecloses further investigation by providing a recognised label that absorbs the clinical uncertainty without resolving it.
Because the classification system has no intrinsic mechanism for signalling its own misfit, these closures can persist indefinitely. Nothing within the diagnostic manual alerts the system to its own inadequacy. The suffering continues in the actual texture of people's lives. The body goes on failing, the social relations go on thinning, the dwelling goes on deteriorating. But the symbolic system does not register this as a failure of its categories. It registers it, if at all, as a failure of the patient to respond to treatment.
III. Distributed Recognition Regimes: Two Architectures
The most important structural feature of recognition, and the one most consistently overlooked in the existing literature, is its distribution across multiple institutional regimes. Recognition is not located in the clinical encounter. It depends on the partial alignment of clinicians, diagnostic systems, employers, insurers, welfare agencies, families, patient communities, digital platforms, legal structures, and public discourse. The failure that both texts document is not simply a failure of medicine to see. It is a failure of alignment across this chain, a failure that compounds at each link because each institution waits for the one before it to act.
Mendenhall's and Bradley's texts map two different versions of this distributed architecture, and the structural difference between them is illuminating.
In Mendenhall's material, the recognition chain is tightly coupled to material and economic outcomes, and clinical recognition functions as its switching node. Without a formal diagnosis, insurance does not reimburse tests or treatment. Without insurance coverage, specialist access is denied. Without specialist access, clinical recognition is further delayed. Without clinical recognition, employment accommodation is impossible. Without employment accommodation, income collapses. Without income, housing destabilises. Without stable housing, the embodied condition worsens. With a worsened embodied condition, clinical recognition becomes still harder to obtain. The loop is closed and self-reinforcing.
Bethany's story is the purest case. A negative COVID test, obtained because positive tests were unavailable in the early pandemic, contradicted everything her body was undergoing. Without clinical recognition, Medicaid remained inaccessible. Without Medicaid, the specialist who eventually diagnosed her POTS could not be reached. Without the POTS diagnosis, the disability claim could not proceed. Without the disability claim, the attorney who saved her house from foreclosure could not have made the case. The recognition failure was not an epistemic problem at root. It was a cascade of material consequences, each locked behind the symbolic gate of clinical classification.
But Bethany found recognition in another site entirely: the long COVID Facebook support group. This recognition was structurally different in every way. It was not performed by an authorised actor in the institutional sense. It did not generate downstream legal or economic consequences directly. What it did was restore something that had collapsed as thoroughly as her income and her housing: the sense of being among others who share the experience, who validate it as real, who possess practical knowledge of how to navigate a medical system that is failing her. It was through this community that she learned of the functional medicine doctor who eventually diagnosed her. The community-based recognition was not a consolation for the absence of clinical recognition. It was the practical infrastructure through which clinical recognition eventually became reachable.
In Bradley's material, the recognition architecture is organised differently, and the difference reveals the range of what recognition can mean. The material stakes of recognition for body-focused repetitive behaviours are lower than for long COVID. Trichotillomania and skin picking rarely trigger the cascading welfare consequences that follow from unrecognised long COVID, because they do not typically gate sick leave, disability entitlements, or insurance coverage in the same way. But the being-with stakes of recognition are, for many of Bradley's interlocutors, experienced as even more immediately devastating than the material consequences would be, because these conditions are accompanied by a depth of shame and isolation that Mendenhall's long COVID patients do not typically describe in the same terms. Years of believing oneself to be the only person in the world who does this thing, uniquely strange, uniquely defective, produces a form of suffering that is not primarily economic but is no less real for that.
The foundational recognition event in Bradley's material is finding the name. Someone types "hair pulling" into a search engine and the word trichotillomania appears. This is a symbolic event of extraordinary significance, but it is not clinical recognition in any institutional sense. No clinician is involved. No diagnostic authority has been consulted. What has happened is that the person's felt experience, the compulsion that was uniquely shameful and uniquely isolating, has been given a name, and the name refers to a condition that other people also have. This is simultaneously recognition of the condition as a real thing in the world and recognition of the existence of others who share it.
The DSM classification matters in this context not primarily because it unlocks clinical care. Bradley's interlocutors are consistently disappointed by clinical encounters, which typically end in either ignorance or inadequate response. The diagnostic label matters because it provides the searchable term through which the online community can find and constitute itself. It is functioning here not as a consequential institutional classification that gates welfare entitlements, but as a coordination device that allows dispersed, isolated individuals to locate each other. The first good it produces is not access to care. It is access to others.
This is one of the most important observations in Bradley's work, and it points toward something the standard account of patient advocacy consistently underestimates. Patient advocacy is not only a demand for access to care, research funding, or better diagnostic classification. It is a demand for access to others. The long COVID Facebook group, the BFRB online community, the Body Politic WhatsApp channel: these are not preparatory stages before politics begins. They are themselves one of the central forms of repair. The group is not secondary to advocacy. It is a form of recognition, stabilisation, and mesocosmic repair in its own right.
The comparison between the two recognition architectures illuminates how the severity of recognition failure is shaped by the tightness of the coupling between medical classification and material-institutional consequence. Where that coupling is tight, as with long COVID and ME/CFS, the failure of clinical recognition produces total collapse across all dimensions of a person's life simultaneously. Where the coupling is looser, as with BFRBs, the failure produces primarily being-with suffering and symbolic isolation, which is serious and disabling but differently structured. This difference also shapes the form that advocacy takes. In Mendenhall's material, advocacy is directed primarily at the clinical-institutional recognition that gates material consequences: patients lobby for diagnostic reclassification, demand research funding, contest clinical trial methodology. In Bradley's material, advocacy is directed at visibility, awareness, and the construction of public symbolic presence for conditions whose primary harm is isolation and shame.
The recognition actors across both texts form a consistent pattern that deserves explicit attention. Medical clinicians occupy a position of structural authority without matching competence. They are the gatekeepers of the recognition that matters most institutionally, but they are frequently unable to provide it: the conditions lack the biomarker profile the verification system requires, clinical training has not covered them, the rushed architecture of clinical encounters prevents the extended attention the complexity demands. The actor with the most institutional authority to grant consequential recognition is among the least capable of doing so.
Functional and integrative medicine clinicians appear in Mendenhall's material as practitioners who eventually provide recognition after conventional medicine has failed. Their recognition carries institutional weight, but it operates on different epistemic grounds, attending to lived complexity rather than demanding biomarker verification. The doctor who finally diagnosed Bethany believed her symptoms were real even when they did not make complete sense to him. This is clinical recognition that remains faithful to felt misalignment rather than requiring its translation into authorised categories before proceeding.
Employers, HR systems, and welfare agencies appear in Mendenhall's material as recognition actors whose decisions have direct material consequences but who are almost entirely dependent on clinical recognition as their input. They translate clinical recognition, or its absence, into economic outcomes. Each institutional actor waits for the symbolic signal from medicine before acting, and when that signal does not come, the entire chain stalls. Family and informal social networks show a consistent pattern across both texts: initial recognition, often generous, followed by gradual withdrawal as illness extends beyond what informal recognition can sustain. Friends stop calling. Partners express scepticism. This withdrawal of relational recognition is not primarily cruelty. It is the structural consequence of how recognition in close relationships is produced: through the coordination of shared daily life, which illness removes.
What neither text pauses to examine is the specific technical affordances of the digital platforms through which patient communities form and sustain themselves. The Body Politic long COVID community began as a WhatsApp group. The BFRB communities Bradley studied are primarily Facebook groups. WhatsApp's specific properties: synchronous and asynchronous messaging, easy group formation, the sense of safety that encryption provides, low cost, global availability, mean that the recognition infrastructure it supports is not merely a faster version of earlier forms of patient community. It creates a different kind of recognition space: intimate at scale, globally distributed but locally felt, available at the moment of crisis rather than only during scheduled support group hours. The recognition that changed lives for Bradley's interlocutors was mediated through the specific properties of internet search, the way a symptom description returns a diagnostic term that opens a community, and through Facebook's group architecture, which allows global connection at effectively zero marginal cost. A recognition infrastructure of this kind did not exist twenty years ago in any form that could have served the populations both texts describe.
IV. The Historical Production of Recognition-Dependent Suffering
The recognition crisis that both texts document is not a universal feature of human suffering. It is a historically produced consequence of the convergence of several distinct mediational conditions, assembled across the last century and a half, none of which alone was sufficient, and all of which had to be simultaneously in place for the phenomenon both texts describe to exist at the scale and in the form it takes today.
The most powerful evidence for the historical specificity of this phenomenon is its absence in other medical traditions. Organised patient groups lobbying for recognition of a specific diagnostic label, demanding to be classified as ME/CFS rather than CFS, as long COVID rather than functional disorder, as dysautonomia rather than anxiety, as BFRB rather than impulse control disorder: this is a historically specific form of collective action that the specific form of patient advocacy centred on securing recognition through an authoritative diagnostic label does not appear to arise in Ayurvedic, classical Chinese, or humoral medical traditions. This is not because people in those traditions do not suffer, or do not organise around shared experiences of illness. It is because those traditions do not couple diagnostic classification to welfare entitlement, employment accommodation, insurance reimbursement, and legal credibility through a centralised verification apparatus. The scenario in which patients lobby for one diagnostic classification over another is literally inconceivable within Ayurveda, because nothing like the institutional stakes of biomedical classification exists there. No one petitions the vaidya to reclassify their condition as a vata-pitta derangement rather than a vata-kapha derangement. The form is unavailable because the institutional configuration that would give it stakes does not exist.
Five conditions converged to produce the modern recognition crisis. The first three generated the bottleneck. The fourth made the bottleneck contestable. The fifth made contestation scalable.
The foundational condition is the institutional coupling of medical certification to economic entitlement. The decisive historical moment is Bismarck's sickness insurance legislation of 1883, which created for the first time a state-mandated system in which a doctor's certificate was the required gateway to economic protection against illness. Before this legislation, illness might attract charity, religious care, or family support, but not a state-backed economic entitlement that depended on and thereby empowered medical certification. Once this coupling was established, the stakes of medical recognition transformed entirely. The diagnosis ceased to be merely a description of what was wrong. It became the key that unlocks or withholds the material infrastructure of survival. This coupling spread unevenly across industrialising societies through the late nineteenth and early twentieth centuries, taking different forms in different national contexts but establishing everywhere the same structural principle: medical verification gates economic entitlement. By the mid-twentieth century, the coupling was so thoroughly normalised as to appear simply natural, as if it had always been the case that a doctor's word was required before support could be provided to a sick person.
The second condition is the elimination of non-medical explanations for suffering from institutional recognition. In social systems where suffering is explained through karma, divine punishment, spiritual imbalance, or moral failing, the struggle for biomedical classification is not merely difficult but conceptually unavailable. You cannot take certified sick leave in a system that attributes your suffering to karma, because that system does not route through medical certification. The progressive secularisation of institutional life in modern states, and the corresponding monopolisation of legitimate institutional suffering-recognition by biomedical categories, created the epistemic space within which medical diagnosis became the only institutionally valid form of suffering-recognition. This elimination is never total at the level of lived experience: people continue attributing their suffering to many non-biomedical causes in their daily lives. But at the level of formal institutional response, welfare entitlement, employment accommodation, legal protection, biomedicine has achieved something close to a monopoly on recognised explanation. This monopoly is what gives the diagnostic label its extraordinary power and what makes fighting over diagnostic labels so consequential.
The third condition is the formalisation of employment as the primary source of income. When most people derive their income from formal employment relationships governed by explicit contracts and legal protections, sick leave becomes an economic institution of central importance. The transformation from agricultural, artisanal, and informal economic arrangements to wage labour, the central economic process of the nineteenth and twentieth centuries in industrialising societies, creates the stakes that make medical certification economically decisive. Where this coupling is weaker, as with the BFRB cases that Bradley documents, the recognition stakes are correspondingly different: primarily social and psychological rather than material-economic, and the advocacy takes a correspondingly different form.
Together, these three conditions produce the modern recognition bottleneck: a configuration in which medical classification is the gateway to economic survival, non-medical explanations have been institutionally eliminated, and formal employment has made the stakes of sick leave certification acute. In this configuration, the failure of clinical recognition cascades automatically and immediately into material failure across every other institutional domain.
The fourth condition makes the bottleneck contestable. For most of the history of modern biomedicine, the appropriate patient response to clinical authority was deference. The transformation of this relationship, through the patients' rights movement of the 1960s and 1970s, through the informed consent doctrine, through the legal institutionalisation of patient autonomy, altered the cultural and institutional permissibility of patient advocacy. The AIDS activism moment that Mendenhall correctly identifies as foundational for subsequent patient advocacy was possible precisely because this transformation had occurred: activists with AIDS could challenge scientific authority, demand seats at research tables, and contest the methodology of clinical trials in ways that would have been culturally and institutionally inconceivable a generation earlier. Without this transformation, the ME/CFS community could not have contested the PACE Trial. The long COVID community could not have demanded representation at National Academies meetings. Bradley's BFRB community could not have lobbied for DSM reclassification. Patient advocacy requires not only high stakes but also a cultural permission structure that treats patient experience as legitimate evidence rather than noise to be filtered out by expert authority.
The fifth condition makes contestation scalable. The recognition communities central to both texts are not possible without technical affordances that are historically very recent. Three phases can be distinguished. The first phase, roughly 1995 to 2005, created static patient information resources: websites, early forums, symptom databases searchable by lay users. This is what allows Bradley's interlocutors to type "hair pulling" into a search engine and find the word trichotillomania. The discovery of the name, which both texts identify as a foundational recognition event, depends entirely on this infrastructure. It could not have happened in 1975. The isolation that Bradley's interlocutors describe spending years or decades within was not a contingent consequence of bad luck. It was the structural condition of a world without these platforms.
The second phase, roughly 2005 to 2015, created interactive and community-generating platforms. The e-patient movement that emerged in this period theorised for the first time the patient as an active producer of health knowledge rather than a passive recipient of clinical expertise. The figure of the equipped, enabled, empowered, and engaged patient, who researches, connects, advocates, and challenges clinical authority from a position of informed community solidarity, is a product of this phase. The third phase, roughly 2015 to the present, created the messaging and community infrastructure that both texts depend on most directly. The Body Politic long COVID community began as a WhatsApp group. WhatsApp's specific affordances, synchronous and asynchronous messaging, easy group formation, low cost, global availability, created a recognition space qualitatively different from what preceded it: intimate at scale, globally distributed but locally felt, available at the moment of crisis rather than only during scheduled hours. This is not merely a faster version of a telephone tree or a letter-writing network. It creates a different kind of community with different possibilities for the circulation of knowledge, recognition, and care.
The five conditions did not converge gradually and evenly. Their convergence was uneven, partial, and contested at every stage. But by the time the COVID-19 pandemic began in 2020, all five were sufficiently in place in wealthy industrialised countries that the long COVID recognition crisis could unfold in the form that Mendenhall documents: millions of people with real suffering, unable to pass through clinical verification systems, fighting for diagnostic recognition in order to access the welfare, employment, and healthcare systems whose support they desperately needed, and organising at extraordinary speed through digital platforms to build the recognition infrastructure that formal medicine was failing to provide.
V. Patient Communities as Mesocosmic Repair
Bradley's concept of the circle of biosolidarity is one of the most structurally precise observations in either text. Her argument is that biosociality and advocacy are mutually reproductive: finding the community inspires some people to advocate publicly, public advocacy reaches people who have not yet found the community, those people join and some of them advocate, and the circle continues. Liz Atkin drawing on London tubes and giving the drawings to strangers, Lauren McKeaney founding The Picking Me Foundation after meeting Liz at a TLC conference: these are not merely heartwarming stories of individual transformation. They are instances of a structural dynamic in which being-with recognition and public symbolic recognition reproduce each other.
What Living Value Theory adds to this account is a more precise specification of what the circle is doing and why it works. When clinical and institutional recognition fails, the mesocosm of the affected person collapses across multiple dimensions simultaneously: the body goes untreated, social relations dissolve as others withdraw or never appear, housing destabilises as income collapses, material supports withdraw as insurance and welfare remain inaccessible, and diagnostic classification actively works against the person through labels that foreclose further investigation. The community performs repair across several of these dimensions at once.
Being-with repair is the most immediately felt. The moment that Bradley's interlocutors describe, of discovering that they are not alone, that the experience they believed uniquely strange and uniquely shameful is shared by others, is not merely psychologically comforting. Being-with is one of the irreducible dimensions through which human life is organised. Its restoration restores one of the foundations of coordination that has collapsed, and that restoration has real consequences for the person's capacity to navigate the other collapsed dimensions.
Symbolic repair operates alongside being-with repair. When the community generates a shared vocabulary, the names of conditions, the language of post-exertional malaise, the discourse of patient expertise, the terminology of dysautonomia, it is performing articulation of experiences that have been stuck in the pre-symbolic register of felt but unnamed suffering for months or years. This is not a small thing. The movement from inarticulate felt misalignment to communicable symbolic articulation is the movement from private suffering to shared experience, from isolation to the possibility of solidarity.
But the most original observation that both texts together generate, and the one most consistently underestimated in the standard account of patient advocacy, is this: the first good produced by many patient communities is not policy change, clinical recognition, or research funding. It is access to others. This is not a preparatory stage before the real politics begins. It is itself one of the central forms of repair.
The circle of biosolidarity is not primarily a political mechanism, though it has political effects. It is primarily a recognition mechanism: a way of generating, within the community itself, the being-with and symbolic recognition that formal institutions have failed to provide, and then projecting that recognition outward into the public domain where it can reach others who remain in isolation. The external dimension of advocacy, lobbying for DSM reclassification, contesting clinical trial methodology, demanding research funding, is the attempt to translate the recognition the community has established internally into the institutional recognition that only formal systems can grant and that gates the material consequences that determine whether people can live viable lives.
The limits of what community-based repair can achieve are equally real, and both texts gesture toward them without making them fully explicit. The being-with and symbolic recognition that online communities provide, however valuable, does not transfer automatically to the institutional domains where the most consequential recognition decisions are made. The long COVID Facebook group validates Bethany's suffering and connects her with practical knowledge. It does not give her a diagnosis that unlocks Medicaid. The BFRB community gives Michael the felt sense of belonging that his years of isolated shame had denied. It does not give him a clinician who can treat him effectively. The community performs repair within the dimensions it can reach. The material-institutional chain remains broken until formal recognition is achieved.
This is why the people whom both texts document are not only fighting to be seen. They are fighting for a much more specific and consequential operation: for lived suffering to become institutionally transmissible recognition. The community creates the conditions of solidarity and survival within which that fight can be sustained. But the fight itself is directed at something the community alone cannot provide.
VI. Conclusion: What the Recognition Crisis Reveals
The hysteria-to-long-COVID arc that Mendenhall traces, and the trichotillomania-to-BFRB arc that Bradley traces, are sometimes read as stories of progress impeded: conditions that have always existed, repeatedly mishandled by institutions that should do better. They can also be read differently: as stories of a specific civilisational configuration generating, with remarkable consistency, both the recognition failure and the organised response to it.
The recognition crisis is not accidental. It is structurally produced by the convergence of medical certification coupled to economic entitlement, the institutional elimination of non-medical explanations, the formalisation of employment as the primary income source, the cultural legitimation of patient voice, and the emergence of digital platforms that make community formation and advocacy scalable. When these conditions converge, the recognition crisis and the patient advocacy response become structurally predictable. They are the systematic output of a configuration that was never designed for the range of human suffering it now claims to govern.
Recognition, properly understood, is not a simple seeing but a consequential institutional classification, and its distribution across multiple regimes means that its failure is correspondingly distributed across the clinical encounter, the insurance decision, the employer's response, the family's reaction, and the public's understanding. Invisible illness names the structural position of suffering that cannot achieve stable alignment across this chain. The person in this position is not unseen. They are caught between a lived reality that is unambiguous in its immediacy and a symbolic system that lacks the categories to make that reality institutionally transmissible.
The three most important contributions of both texts together, contributions that neither makes fully explicit but that the comparative reading makes visible, are these. Recognition is distributed across regimes, not located in the clinic: the alignment problem is where the analysis must focus. Invisible illness is a structural position, not a disease property: the same position can be occupied by workplace harm, neurodivergence, and other forms of suffering that exceed what institutional categories can admit. And patient advocacy creates access to others, not merely access to biomedical recognition: the community is a form of repair in its own right, not a precondition for the real politics.
Mendenhall ends her book with a call for a culture of care more responsive to the complexity of lives lived with unverifiable illness. Bradley ends her article with a commitment to biosolidarity as both concept and method, and a vision of the circle continuing to expand. Both endings are the right ones for the books they close.
What Living Value Theory adds is a vocabulary for why the problem has the structure it does, and therefore for what it would mean to address it at the structural level rather than at the margins. The recognition chain was assembled historically, which means it can, in principle, be reassembled differently. The coupling between medical certification and economic entitlement is not a law of nature. The elimination of non-medical explanations from institutional recognition was a historical choice, not a necessity. The dependence of advocacy on digital platforms is a recent development whose specific affordances could be designed differently.
Making the structure visible is the precondition for asking what it would mean to change it. Both texts make it more visible than it was. This essay has tried to show the architecture beneath what they see.
References
Bradley, B., 2021. From biosociality to biosolidarity: the looping effects of finding and forming social networks for body-focused repetitive behaviours. Anthropology & Medicine 28(4): 543-557.
Mendenhall, E., 2026. Invisible Illness: A History, from Hysteria to Long COVID. Berkeley: University of California Press.